{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:10:37Z","timestamp":1790878237612,"version":"4.1.0"},"reference-count":12,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The Transfusion\u2010Transmissible Infections Monitoring System (TTIMS) combines data from four US blood collection organizations including approximately 60% of all donations to monitor demographic and temporal trends in infectious disease markers and policy impacts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study Design and Methods<\/jats:title><jats:p>Human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) consensus\u2010positive definitions combined serology and nucleic acid testing results. These along with donor and donation characteristics were assembled into a single data set. Overall donation prevalence and demographic subsets were compared pre\u2010 and post\u2010implementation of the 2015 change in men who have sex with men (MSM) deferral policy, among other prevalence comparisons.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From October 2015 to September 2019, there were 712 HIV\u2010, 1735 HBV\u2010, and 5217 HCV\u2010positive samples identified from approximately 27.5 million donations (&gt;9.4 million donors). Prevalences per 100\u2009000 donations were 2.6 (HIV), 6.3 (HBV), and 19.0 (HCV), and the highest for all three agents were in donations from first\u2010time male donors. Two slight but significant increases in HIV prevalence were observed, both for comparisons of Year 1 (pre\u2010MSM policy change) versus Year 4 (post\u2010MSM policy change) for first\u2010time males and first\u2010time females; in contrast, similar comparisons demonstrated decreases in HCV prevalence (all donors and general trends for males and females). Except for HIV, prevalence increased with age; for all agents, prevalence was markedly higher in the south.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>No major trends were observed over 4\u2009years covering the MSM policy change from indefinite to a 12\u2010month deferral, but ongoing monitoring is warranted. Demographic trends are consistent with those observed in other donor studies and community trends.<\/jats:p><\/jats:sec>","DOI":"10.1111\/trf.16005","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T03:36:56Z","timestamp":1598931416000},"page":"2327-2339","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Prevalence of <scp>human immunodeficiency virus<\/scp>, <scp>hepatitis B virus,<\/scp> and <scp>hepatitis C virus<\/scp> in United States blood donations, 2015 to 2019: The <scp>Transfusion\u2010Transmissible<\/scp> Infections Monitoring System (<scp>TTIMS<\/scp>)"],"prefix":"10.1111","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-3115","authenticated-orcid":false,"given":"Whitney R.","family":"Steele","sequence":"first","affiliation":[{"name":"American Red Cross  Gaithersburg Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger Y.","family":"Dodd","sequence":"additional","affiliation":[{"name":"American Red Cross  Gaithersburg Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward P.","family":"Notari","sequence":"additional","affiliation":[{"name":"American Red Cross  Gaithersburg Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Xu","sequence":"additional","affiliation":[{"name":"American Red Cross  Gaithersburg Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Nelson","sequence":"additional","affiliation":[{"name":"American Red Cross  Gaithersburg Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra A.","family":"Kessler","sequence":"additional","affiliation":[{"name":"New York Blood Center  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Reik","sequence":"additional","affiliation":[{"name":"OneBlood  St. Petersburg Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan E.","family":"Williams","sequence":"additional","affiliation":[{"name":"U.S. Food and Drug Administration  Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Custer","sequence":"additional","affiliation":[{"name":"Vitalant Research Institute  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5865-6366","authenticated-orcid":false,"given":"Susan L.","family":"Stramer","sequence":"additional","affiliation":[{"name":"American Red Cross  Gaithersburg Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Transfusion\u2010Transmissible Infections Monitoring System (TTIMS)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,8,31]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"US Food and Drug Administration.Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products\u2010Guidance for Industry. Silver Spring MD: US Food and Drug Administration 2015."},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13632"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13759"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2020.02.001"},{"key":"e_1_2_7_6_1","unstructured":"Estimated HIV incidence and prevalence in the United States 2010\u20102016. HIV Surveillance Supplemental Report 2019; 24(1). Centers for Disease Control and Prevention Web site http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html. Last reviewed June 08 2020."},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28109"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.6371"},{"key":"e_1_2_7_9_1","first-page":"9A","article-title":"Detection of antiretroviral therapy use in US blood donors","volume":"59","author":"Custer B","year":"2019","journal-title":"Transfusion"},{"key":"e_1_2_7_10_1","first-page":"8A","article-title":"Infectious disease (ID) rates among donors reinstated after changes to the men who have sex with other men (MSM) deferral policy","volume":"58","author":"Miller YM","year":"2018","journal-title":"Transfusion"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13891"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00174.x"},{"key":"e_1_2_7_13_1","unstructured":"Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products \u2010 Guidance for Industry. US Food and Drug Administration Web site https:\/\/www.fda.gov\/regulatory\u2010information\/search\u2010fda\u2010guidance\u2010documents\/revised\u2010recommendations\u2010reducing\u2010risk\u2010human\u2010immunodeficiency\u2010virus\u2010transmission\u2010blood\u2010and\u2010blood. Accessed June 08 2020."}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.16005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/trf.16005","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.16005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T10:19:36Z","timestamp":1693822776000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.16005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1111\/trf.16005"],"URL":"https:\/\/doi.org\/10.1111\/trf.16005","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,31]]},"assertion":[{"value":"2020-04-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}